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Abstract 17 
The molecular weight of chitosan is one of its most determinant characteristics, which 18 
affects its processability and its performance as a biomaterial. However, information 19 
about the effect of this parameter on the formation of electrosprayed chitosan 20 
microcapsules is scarce. In this work, the impact of chitosan molecular weight on its 21 
electrosprayability was studied and correlated with its effect on the viscosity, surface 22 
tension and electrical conductivity of solutions. A Discriminant Function Analysis 23 
revealed that the morphology of the electrosprayed chitosan materials could be correctly 24 
predicted using these three parameters for almost 85% of the samples. The suitability of 25 
using electrosprayed chitosan capsules as carriers for bioactive agents was also assessed 26 
by loading them with a model active compound, (Ð)-epigallocatechin gallate (EGCG). 27 
This encapsulation, with an estimated efficiency of around 80% in terms of preserved 28 
antioxidant activity, showed the potential to prolong the antiviral activity of EGCG 29 
against murine norovirus via gradual bioactive release combined with its protection 30 
against degradation in simulated physiological conditions. 31 
32 
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1. Introduction 35 
Micro- and nanoencapsulation, processes in which a compound is embedded within a 36 
protective matrix (Jiménez-Martín, Gharsallaoui, Pérez-Palacios, Carrascal & Rojas, 37 
2014) which is organized in the form of micro- or nanosized structures, have attracted 38 
increasing research interest for the protection of sensitive bioactive compounds (Pérez-39 
Masiá, López-Nicolás, Periago, Ros, Lagaron & López-Rubio, 2015) and address 40 
current concerns related to their formulation, bioavailability or their delivery to specific 41 
sites (Zaki, 2014). 42 
Among the different techniques used for microencapsulation, electrohydrodynamic 43 
spraying (electrospraying) is rapidly emerging as a promising technology for the  44 
production of polymeric microparticles containing bioactive molecules (Bock, 45 
Dargaville & Woodruff, 2012), as it overcomes some of the limitations of conventional 46 
methods. Electrospraying can generate microencapsulation structures in a one-step 47 
process (Chakraborty, Liao, Adler & Leong, 2009) under mild conditions (López-Rubio 48 
& Lagaron, 2012; Sosnik, 2014) and in the absence of organic/toxic solvents (Tapia-49 
Hernández et al., 2015), limiting inactivation of the bioactive compounds (Zamani, 50 
Prabhakaran & Ramakrishna, 2013), being adequate for both hydrophilic and 51 
hydrophobic drugs or ingredients (Gómez-Mascaraque & López-Rubio, 2016) and 52 
generally achieving high loading efficiencies (Sosnik, 2014; Zamani, Prabhakaran & 53 
Ramakrishna, 2013). Therefore, it has found a number of potential applications in 54 
various fields, including the pharmaceutical, cosmetic and food industries (Jaworek & 55 
Sobczyk, 2008). It basically consists on subjecting a polymer solution (containing the 56 
bioactive to be encapsulated) to a high voltage so that the electric field deforms the 57 
interface of the liquid drop and breaks it into fine charged droplets, which are ejected 58 
towards a collector while the solvent evaporates, generating dry polymeric 59 
microparticles (Anu Bhushani & Anandharamakrishnan, 2014; Sosnik, 2014). 60 
Biopolymers are preferred as encapsulating matrices for most applications because of 61 
their biocompatibility, biodegradability and non-toxicity (Ghorani & Tucker, 2015). 62 
Specially, chitosan is a biorenewable, biocompatible and biodegradable polysaccharide 63 
considered a GRAS food additive by the FDA (Luo & Wang). Moreover, it has many 64 
attributed functional and bioactive properties, including antioxidant and lipid-lowering 65 
capacities, antimicrobial activity, wound healing and antiangiogenic effects, prevention 66 
of renal failure, etc. (Luo & Wang; Park, Saravanakumar, Kim & Kwon, 2010; Ribeiro 67 
et al., 2009). For these reasons chitosan and its derivatives have been widely used in the 68 
pharmaceutical (Badwan, Rashid, Omari & Darras, 2015; Cheung, Ng, Wong & Chan, 69 
2015), biomedical (Anitha et al., 2014; Ishihara, 2015), cosmetic (Anumansirikul, 2007; 70 
Jimtaisong & Saewan, 2014) and food industries (Fathi, Martin & McClements, 2014; 71 
Zivanovic, Davis & Golden, 2014), and is considered a good candidate for the 72 
encapsulation of bioactive compounds (Estevinho, Rocha, Santos & Alves, 2013; 73 
Varshosaz, 2007). However, the electrohydrodynamic processing of chitosan is 74 
complex due to its particular behavior in solution and its polycationic nature 75 
(Homayoni, Ravandi & Valizadeh, 2009), consequence of its structure consisting of -76 
1,4 linked 2-acetamido-2-deoxy--D-glucopyranose units and 2-amino-2-deoxy-b-D-77 
glucopyranose units (cf. Figure S1 of the Supplementary Material) (Khor & Lim, 2003). 78 
The electrohydrodynamic spinning (electrospinning) of chitosan for the production of 79 
nanofibers from non-toxic solvents has been extensively studied (Sun & Li), and the 80 
impact of different processing parameters, solution properties and/or the molecular 81 
weight of the polymer on the morphology of the obtained fibers have been addressed 82 
(Geng, Kwon & Jang, 2005; Homayoni, Ravandi & Valizadeh, 2009). However, as the 83 
focus of these works is the manufacture of fibers, the range of explored conditions does 84 
not cover the production of nano/microparticles. The use of electrospraying for the 85 
production of dry (Arya, Chakraborty, Dube & Katti, 2009; Zhang & Kawakami, 2010) 86 
or gelled (Pancholi, Ahras, Stride & Edirisinghe, 2009; Wang et al., 2015; Yunoki, 87 
Tsuchiya, Fukui, Fujii & Maruyama, 2014) chitosan micro- and nanospheres has also 88 
been reported, however, all these works use only one particular grade of chitosan, with a 89 
fixed molecular weight. Given that the molecular weight of chitosan is one of its key 90 
characteristics, which can affect not only its processability but also its performance as a 91 
delivery vehicle (Arya, Chakraborty, Dube & Katti, 2009), the focus of this work was to 92 
study the influence of the molecular weight on the sprayability of chitosan, and to assess 93 
the suitability of selected electrosprayed capsules as delivery vehicles for a model 94 
bioactive compound: (Ð)-epigallocatechin gallate (EGCG). EGCG is the most abundant 95 
and bioactive compound in green tea (Barras et al., 2009) and possesses many attributed 96 
health benefits (Singh, Shankar & Srivastava, 2011), including protective effects against 97 
infections (Steinmann, Buer, Pietschmann & Steinmann, 2013), cardiovascular and 98 
neurodegenerative diseases (Fu et al., 2011), inflammation and arthritis (Singh, Akhtar 99 
& Haqqi, 2010) and cancer (Larsen & Dashwood, 2009, 2010). In the present work, its 100 
antioxidant (Fu et al., 2011) and antiviral (Dhiman, 2011; Xiao, 2008) activities were 101 
assessed before and after encapsulation within the chitosan electrosprayed capsules.      102 
103 
2. Materials and Methods 104 
2.1. Materials 105 
Chitosans with reported degree of deacetylation of 85 ± 2.5 % and different molecular 106 
weights, ranging from 25 to 300 kDa, were purchased from Heppe Medical Chitosan 107 
GmbH. (Ð)-Epigallocatechin gallate (EGCG), 2,2-azino-bis(3-ethylbenzothiazoline-6-108 
sulfonic acid) diammonium salt (ABTS), potassium persulfate (K2O8S2) and 109 
spectroscopic grade potassium bromide (KBr) were obtained from Sigma-Aldrich. 96% 110 
(v/v) acetic acid was supplied by Scharlab.  111 
112 
2.2. Preparation of chitosan solutions 113 
Chitosan solutions of different concentrations, i.e. from 0.5 to 8 % (w/v), were prepared 114 
by dissolving the polysaccharide in acetic acid at room temperature under magnetic 115 
agitation overnight. Different acetic acid concentrations were used for this purpose, 116 
from 20 to 90 % (v/v).  117 
118 
2.3. Characterization of the solutions 119 
The  surface  tension  of  the  solutions  was  measured  using  the  Wilhemy  plate  120 
method  in  an EasyDyne K20 tensiometer (Krüss GmbH, Hamburg, Germany) at room 121 
temperature. 122 
The electrical conductivity of the solutions was measured using a conductivity meter 123 
XS  Con6  (Labbox,  Barcelona,  Spain) at room temperature.  124 
The rheological behaviour of the solutions was studied using a rheometer model AR-G2 125 
(TA Instruments, USA), with a parallel plate geometry, and the method described in 126 
(Gómez-Mascaraque, Lagarón & López-Rubio, 2015). Briefly, continuous shear rate 127 
ramps were performed from 0.1 to 200 s-1 during 15 min at 25 ± 0.1 ºC using a stainless 128 
steel plate with a diameter of 60 mm and a gap of 0.5 mm. All measurements were 129 
made at least in triplicate. 130 
131 
2.4. Electrohydrodynamic processing of the solutions 132 
The solutions were processed using a homemade electrospinning/electrospraying  133 
apparatus,  equipped  with  a  variable  high-voltage  0-30  kV  power  supply. Solutions  134 
were  introduced  in  a  5  mL  syringe  and  were  pumped at a steady flow-rate (0.15 135 
mL/h) through a stainless-steel needle (0.9 mm of inner diameter). The needle was 136 
connected through a PTFE wire to the syringe, which was placed on a digitally 137 
controlled syringe pump. Processed samples were collected on a grounded stainless-138 
steel plate placed at a distance of 10 cm from the tip of the needle in a horizontal 139 
configuration. A voltage of 17 kV was applied to the solutions as selected in 140 
preliminary trials.141 
142 
2.5. Morphological characterization of the particles 143 
Scanning electron microscopy (SEM) was conducted on a Hitachi microscope (Hitachi 144 
S-4800) at an accelerating voltage of 10 kV and a working distance of 7-10 mm. As 145 
prepared samples were sputter-coated with a gold-palladium mixture under vacuum 146 
prior to examination. 147 
148 
2.6. Fourier transform infrared (FT-IR) analysis of the particles 149 
Samples (ca. 1-2 mg) of selected chitosan capsules, both unloaded and EGCG-loaded, 150 
were grounded and dispersed in about 130 mg of spectroscopic grade potassium 151 
bromide (KBr). A pellet was then formed by compressing the samples at ca. 150 MPa. 152 
FT-IR spectra were collected in transmission mode using a Bruker (Rheinstetten, 153 
Germany) FT-IR Tensor 37 equipment. The spectra were obtained by averaging 10 154 
scans at 1 cm-1 resolution. 155 
156 
2.7. Antioxidant activity of free and encapsulated EGCG 157 
The ABTS+ radical scavenging assay (Re, Pellegrini, Proteggente, Pannala, Yang & 158 
Rice-Evans, 1999) was performed in order to quantify the antioxidant activity of both 159 
free and encapsulated EGCG, following the protocol described in a previous work 160 
(Gómez-Mascaraque, Lagarón & López-Rubio, 2015). Briefly, a stock solution of 161 
ABTS+ was prepared by reacting ABTS 7 mM with potassium persulfate 2.45 mM, 162 
both in distilled water, and allowing the mixture to stand in the dark at room 163 
temperature for 24 h. The stock solution was then diluted with acetic acid 20% v/v to an 164 
absorbance at 734 nm of 0.70 ± 0.02. Solutions of free and encapsulated EGCG (0.15 165 
mg/mL of EGCG in both cases) were prepared in acetic acid 20% v/v, and 10 L 166 
aliquots were added to 1 mL of diluted ABTS+, measuring its absorbance at 734 nm 167 
after 1 min of mixing. The unloaded chitosan particles were also evaluated, at the same 168 
polymer concentration as for the loaded samples. The radical scavenging activity 169 
(RSA), expressed as the percentage of reduction of the absorbance at 734 nm after 170 
sample addition, was calculated using Eq. (1), where A0 and A1 are the absorbances at 171 
734 nm of ABTS+ before and 1 min after addition of the samples, respectively.  172 
173 RSA %  -  100        Eq. (1) 174 
175 
Experiments were performed on a V-1200 Spectrophotometer from VWR 176 
(Pennsylvania, USA), at least in triplicate. Solvent blanks were also run in each assay. 177 
178 
2.8. Microencapsulation efficiency 179 
The microencapsulation efficiency (MEE) of the EGCG-loaded capsules was estimated 180 
from the value of their antioxidant activity according to Eq. (2), where both the free and 181 
encapsulated EGCG had the same theoretical concentration in the solutions: 182 
183 
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185 
2.9. Virus strain, cell line and infections 186 
The cytopathogenic murine norovirus (MNV-1) strain, a model for human noroviruses, 187 
was propagated and assayed in RAW 264.7 (kindly provided by Prof. H. W. Virgin, 188 
Washington University School of Medicine, USA) as described in Elizaquível, 189 
Azizkhani, Aznar and Sánchez (2013). Semi-purified stocks were subsequently 190 
produced from the same cells by centrifugation of infected cell lysates at 660×g for 30 191 
min. Infectious viruses were enumerated by determining the 50% tissue culture 192 
infectious dose (TCID50) with eight wells per dilution and 20 l of inoculum per well.  193 
194 
2.10. Antiviral activity 195 
Different concentrations of free and encapsulated EGCG were added to MNV 196 
suspensions (ca. 6 log TCID50/mL) and further incubated at 37 °C in a water-bath 197 
shaker at 150 rpm for 2 or 16 h (ON). Ten-fold dilutions of treated and untreated virus 198 
suspensions were inoculated into confluent RAW monolayers in 96-well plates. Then, 199 
infectious viruses were quantified by cell culture assays as described above. Each 200 
treatment was done in triplicate. Positive controls were virus suspensions in PBS and 201 
virus suspensions added to unloaded chitosan capsules. The decay of MNV was 202 
calculated as log10 (Nt/N0), where N0 is the infectious MNV titer for untreated sample 203 
and Nt is the infectious MNV titer for treated samples. 204 
205 
2.11. Statistical analysis 206 
A statistical analysis of experimental data was performed using IBM SPSS Statistics 207 
software (v.23) (IBM Corp., USA). Significant differences between homogeneous 208 
sample groups were obtained through two-sided t-tests (means test of equality) at the 209 
95% significance level (p < 0.05). For multiple comparisons, the p-values were adjusted 210 
using the Bonferroni correction. This software was also used to carry out a Discriminant 211 
Function Analysis (DFA) (cf. Section 3.2.3). 212 
213 
3. Results and discussion 214 
3.1. Impact of the molecular weight on the morphology of electrosprayed chitosan  215 
The use of electrospraying for the production of chitosan micro- and nanospheres for 216 
drug delivery applications, and the influence of different processing parameters on the 217 
obtained materials has already been reported for specific chitosans (Arya, Chakraborty, 218 
Dube & Katti, 2009; Maeng, Choi, Kim & Kim, 2010; Pancholi, Ahras, Stride & 219 
Edirisinghe, 2009; Yunoki, Tsuchiya, Fukui, Fujii & Maruyama, 2014; Zhang & 220 
Kawakami, 2010). However, there is lack of information about the influence that the 221 
molecular weight of chitosan itself has on the morphology of the materials obtained 222 
through electrospraying. Thus, the formation of microencapsulation structures through 223 
electrospinning/electrospraying using different chitosans with varying molecular 224 
weights (Mw) and in a wide range of concentrations was evaluated under the same 225 
processing conditions (i.e. an applied voltage of 17 kV, a flow rate of 0.15 mL/h and a 226 
needle-collector distance of 10 cm), which were selected in preliminary trials so as to be 227 
able to process all the solutions. The mean degree of deacetylation (DDA) of all 228 
chitosans was 85% (± 2.5 %), and they were all dissolved in 90% acetic acid based on 229 
previous works (Arya, Chakraborty, Dube & Katti, 2009; Pérez-Masiá, Lagaron & 230 
Lopez-Rubio, 2015; Zhang & Kawakami, 2010). Figure 1 summarizes the types of 231 
morphologies obtained for the different Mw-concentration pairs tested, showing the 232 
micrographs obtained by SEM for some representative samples. 233 
234 
Figure 1. Combined effect of molecular weight and concentration on the morphology of 235 
electrosprayed chitosan materials. White scale bars in all the SEM micrographs represent 2 µm. 236 
The results revealed that there was a small range of Mw-concentration conditions which 237 
yielded neat electrosprayed particles under the selected processing parameters. Small 238 
deviations from these conditions either caused fiber formation or dripping of the 239 
chitosan solutions. As expected, an increase in the molecular weight of chitosan caused 240 
a decrease in the concentration at which it could be successfully electrosprayed. Indeed, 241 
as the molecular weight of a polymer increases, so does the frequency of chain 242 
entanglements and thus the intermolecular cohesion in solution for a fixed 243 
concentration. The formation of chain entanglements has been acknowledged as the 244 
main factor determining the different morphologies which can be obtained when a 245 
polymer solution is processed electrohydrodynamically (Shenoy, Bates, Frisch & Wnek, 246 
2005). Accordingly, when a sufficient entanglement concentration is reached, jet 247 
fragmentation during processing is prevented and fibers are formed (Gómez-248 
Mascaraque, Lagarón & López-Rubio, 2015). In a polymer solution, the number of 249 
chain entanglements is affected both by the concentration and the molecular weight of 250 
the polymer  (Shenoy, Bates, Frisch & Wnek, 2005), and is related to the viscosity of 251 
the solutions (Cross, 1970). Thus, in order to better understand the influence of the 252 
molecular weight on the morphology of the processed materials, the rheological 253 
behaviour of the chitosan solutions was examined, together with other solution 254 
properties (surface tension and electrical conductivity) that are known to strongly 255 
impact electrohydrodynamic processing (Pérez-Masiá, Lagaron & López-Rubio, 2014). 256 
257 
3.2. Chitosan solution properties 258 
3.2.1. Rheological behaviour 259 
In general, the most diluted chitosan solutions exhibited a Newtonian behavior, with a 260 
linear relationship between the shear stress () and the shear rate ( ), regardless of the 261 
molecular weight of the polymers. However, as the concentration increased, the 262 
chitosan samples showed a shear thinning (pseudoplastic) behavior as previously 263 
reported (Iversen, Kjøniksen, Nyström, Nakken, Palmgren & Tande, 1997), which was 264 
manifested at lower concentrations for the higher molecular weight chitosans, and was 265 
more evident as both the chitosan concentration and its molecular weight increased. 266 
Figure S2 of the Supplementary Material shows the rheological profiles obtained for 267 
different concentrations of chitosan with a molecular weight of 150 kDa, as a 268 
representative example. In order to compare the viscosity of the different chitosan 269 
solutions, its value at a constant high shear rate (200 s-1) was plotted against the 270 
polymer concentration for each molecular weight (cf. Figure 2). As predicted by Al-271 
Fariss and Al-Zahrani (1993) for diluted polymer solutions, the viscosity exponentially 272 
increased with the concentration of chitosan at a constant temperature and shear rate, 273 
while a potential relationship of the viscosity of chitosan solutions with its molecular 274 
weight was observed (cf. Figure S3 of the Supplementary Material) as predicted by the 275 
MarkÐHouwink equation (Kasaai, 2007; Wang, Bo, Li & Qin, 1991). Overall, the 276 
viscosity could be increased either by increasing the concentration or the mean 277 
molecular weight of the polysaccharide, as expected. However, the values of the 278 
viscosity alone did not explain the different morphologies obtained, as the ranges of this 279 
parameter which yielded neat particles, particles with fibers or just dripping of the 280 
solution overlapped (cf. Figure S4 of the Supplementary Material). 281 
282 
Figure 2. Viscosity, surface tension and electrical conductivity of chitosan solutions as a function of 283 
the polymer concentration for different molecular weights. 284 
285 
286 
3.2.2. Surface tension and electrical conductivity 287 
The surface tension of the chitosan solutions hardly varied with the molecular weight or 288 
the concentration of the polysaccharide, increasing only slightly as both increased (cf. 289 
Figure 2). This lack of substantial variation with the concentration of biopolymer has 290 
also been observed for other systems (Gómez-Mascaraque, Lagarón & López-Rubio, 291 
2015). 292 
The electrical conductivity initially increased with chitosan concentration for the 293 
different molecular weights evaluated but eventually showed a maximum for the lower 294 
Mw chitosans, i.e. for the solutions where the viscosity allowed evaluation of a wider 295 
range of concentrations (cf. Figure 2). This can be explained taking into account that the 296 
conductivity depends on both the concentration of charges and their mobility. As the 297 
concentration of chitosan, and thus of protonated amino groups increased, the 298 
conductivity augmented up to a point when the viscosity was so high that the mobility 299 
of the charges was hampered. Indeed, these maximum was found at higher 300 
concentrations for lower molecular weights. It was interesting to find that the 301 
concentration at which each chitosan grade was successfully electrosprayed in the form 302 
of neat particles had an electrical conductivity in the increasing slope of the curves, 303 
before the maximum, because the viscosity at higher concentrations was too high and 304 
gave rise to fibrils.  305 
Anyhow, as expected, none of the solution properties could explain the differences in 306 
the morphology of the obtained materials on its own. In contrast, a combination of them 307 
could help predicting the sprayability of chitosan with a specific molecular weight at a 308 
particular concentration. 309 
310 
3.2.3. Combined effect of the solution properties on the morphology 311 
312 
Figure 3. Electrosprayed samples classified by their morphology as a function of the solution 313 
properties 314 
315 
Figure 3 shows the small region where the confluence of certain viscosity, surface 316 
tension and electrical conductivity values yielded electrosprayed particles free of 317 
residual fibrils. In order to ascertain whether these three properties were effective in 318 
predicting the morphology of the electrosprayed materials, a Discriminant Function 319 
Analysis (DFA) was conducted using the software IBM SPSS Statistics (v.23). This 320 
type of statistical analysis is used to determine if a definite set of variables is successful 321 
in predicting a category membership (Rencher, 1992). The DFA revealed that the three 322 
variables were relevant to discriminate the different structures. The best rate of 323 
discrimination was obtained using the combinations of the variables expressed in Eq. 324 
(3) and (4) as standardized canonical discriminant functions, where  is the surface 325 
tension expressed in mN/m,  is the electrical conductivity expressed in (mS/cm) and  326 
is the viscosity expressed in Pas. 327 
	
1  
0.032    0.462    0.928  log
    Eq. (3) 328 
	
2  
1.365    0.0128    0.811  log
    Eq. (4) 329 
With the above discriminant functions, the morphology obtained upon electrospraying 330 
of chitosan solutions could be correctly predicted for 84.2% of the assayed solutions (cf. 331 
Figure 4). Moreover, all solutions leading to neat particles were correctly classified. 332 
333 
Figure 4. Group graphs obtained from the discriminant functions (Eq. (3) and (4)) and 334 
classification results 335 
336 
From the different molecular weight Ð concentration combinations which gave rise to 337 
fiber-free electrosprayed particles, the chitosan with the lowest assayed molecular 338 
weight was selected, as it allowed the highest electrosprayable concentration and thus 339 
the greatest productivity. Thus, the chitosan of 25 kDa at 5% (w/v) concentration was 340 
selected for further analysis. 341 
342 
3.3. Effect of acetic acid concentration 343 
One of the solution parameters that are crucial for the electrohydrodynamic processing 344 
of chitosan solutions is the concentration of the acetic acid solution used as solvent. 345 
While Homayoni, Ravandi and Valizadeh (2009) stated that the acetic acid 346 
concentration should be in the range of 70-90% for optimal electrospinning to obtain 347 
nanofibers, Arya, Chakraborty, Dube and Katti (2009) concluded that the optimum 348 
concentration for successful electrospraying was 90%, though that might only apply for 349 
the particular chitosan they used. This concentration has been selected in other works to 350 
produce electrosprayed particles from chitosan (Pérez-Masiá, Lagaron & Lopez-Rubio, 351 
2015; Sun et al., 2015) without further evaluation. However, Zhang and Kawakami 352 
(2010) extended the range of sprayability (again, for a particular chitosan of high 353 
molecular weight) down to a 50%, noting that decreasing the acetic acid concentration 354 
caused a reduction in the mean particle size. Due to the variability of data found in the 355 
literature in this respect, the concentration of acetic acid was optimized for our 356 
particular system (chitosan 25 kDa, 5% w/v). 357 
358 
Figure 5. Morphology of electrosprayed chitosan (25 kDa, 5% w/v) obtained from different acetic 359 
acid concentrations (90-20% v/v). White scale bars in all the SEM micrographs represent 2 µm. 360 
361 
Figure 5 shows the impact of the acetic acid concentration on the morphology of the 362 
electrosprayed chitosan. It could be observed that concentrations below 80% yielded 363 
particle aggregates and even dripping of the solution for a 20% acetic acid. As the 364 
surface tension of the solutions did not vary significantly with the acetic acid 365 
concentration (cf. Figure S5 of the Supplementary Material), this dripping could be 366 
attributed to a slight decrease in the viscosity of the solutions in combination with a 367 
sharp increase in their electrical conductivity at low acetic concentrations, which had 368 
already been observed by Zhang and Kawakami (2010) and ascribed to the higher 369 
degree of dissociation of the acid at low concentrations. However, a concentration of 370 
80% gave rise to more spherical particles with more homogeneous sizes than the 90% 371 
used in the previous sections. Having both concentrations the same conductivity, this 372 
was attributed to the maximum of viscosity observed at 80% acetic acid (cf. Figure S5 373 
of the Supplementary Material), also patent in the cited work (Zhang & Kawakami, 374 
2010) although not commented. Therefore, an optimum acetic acid concentration of 375 
80% was selected to produce our delivery system. 376 
377 
3.4. Morphological and chemical characterization of EGCG-loaded capsules 378 
The conditions selected in the previous section for the production of electrosprayed 379 
chitosan delivery vehicles where used to produce EGCG-loaded chitosan particles with 380 
a theoretical EGCG content of 10% w/w of the capsules. Figure 6(a) shows a 381 
micrograph of the obtained material, which exhibits a similar morphology as that 382 
obtained in the absence of the bioactive compound, although slightly less homogeneous 383 
in size. 384 
385 
Figure 6. Morphology of EGCG-loaded electrosprayed chitosan particles (a) and infrared spectra 386 
of unloaded and EGCG-loaded electrosprayed chitosan particles (b). The white scale bar in the 387 
SEM micrograph represents 2 µm. 388 
389 
The effective incorporation of EGCG within the chitosan particles was evidenced by the 390 
presence of its characteristic infrared absorption band centred at 1221 cm-1 (cf. Figure 391 
6(b)), as observed for EGCG-loaded spray-dried chitosan particles obtained in a 392 
previous work (Gómez-Mascaraque, Soler & López-Rubio, 2016). This band was 393 
slightly displaced in the capsules with respect to free EGCG, being centred at 1223 cm-1394 
in the latter (spectrum showed elsewhere (Gómez-Mascaraque, Lagarón & López-395 
Rubio, 2015)). Other spectral bands of chitosan were also modified. Specifically, the 396 
Amide I band shifted from 1634 cm-1 in the unloaded particles to 1629 cm-1 in the 397 
EGCG-loaded capsules. These changes suggested the presence of intermolecular 398 
interactions between the bioactive molecule and its biopolymeric vehicle, which might 399 
contribute to the stabilization of the former as previously suggested (Gómez-400 
Mascaraque, Lagarón & López-Rubio, 2015). 401 
402 
3.5. Antioxidant activity and encapsulation efficiency 403 
The ABTS radical cation decolourization assay (Re, Pellegrini, Proteggente, Pannala, 404 
Yang & Rice-Evans, 1999) was used to compare the antioxidant activity of free and 405 
encapsulated EGCG, and to indirectly estimate the encapsulation efficiency of the 406 
system. Therefore, the radical scavenging activities (RSA) of solutions of commercial 407 
EGCG (0.15 mg/mL) and encapsulated EGCG (theoretical concentration of 0.15 408 
mg/mL) in acetic acid 20% v/v, as well as solutions of the unloaded chitosan particles 409 
(same concentration as for the loaded ones) were calculated using Eq. (1). Solvent 410 
blanks were run too.  411 
The results showed no significant differences (p<0.05) between the RSA of the 412 
unloaded chitosan particles (2.3% ± 0.3%) and that of the solvent blank (2.2% ± 0.4%), 413 
suggesting that the polysaccharide exerted no significant antioxidant activity at the 414 
assayed concentration. Hence, the potential contribution of the encapsulating matrix to 415 
the total antioxidant activity of the EGCG-loaded capsules was neglected. The 416 
antioxidant activity of encapsulated EGCG (RSA = 23.0% ± 0.7%) was somewhat 417 
lower than that of free EGCG (RSA = 28.9% ± 1.7%) at the same theoretical 418 
concentration, implying some bioactivity loss during encapsulation. 419 
From these results, the encapsulation efficiency defined by Eq. (2) was estimated to be 420 
79.6% ± 2.4%. This considerably high value was consistent with similar encapsulation 421 
systems based on chitosan used as delivery vehicles for EGCG (Gómez-Mascaraque, 422 
Soler & López-Rubio, 2016). 423 
424 
3.6. Antiviral activity  425 
Table 1 summarizes the results obtained from the antiviral activity assays performed on 426 
murine norovirus. While a concentration of 0.25 mg/mL of EGCG was insufficient to 427 
observe a significant reduction in the recovered titer of the virus after 2 h of incubation, 428 
a concentration of 2.5 mg/mL of the polyphenol did cause a significant reduction, which 429 
was statistically lower for the encapsulated compound suggesting that 2 h was 430 
insufficient for the complete release of the bioactive. On the contrary, when the viruses 431 
were exposed to EGCG overnight, the recovered titer was lower than 1.15 TCID50/mL 432 
for both free and encapsulated EGCG at 2.5 mg/mL and, more interestingly, the 433 
reduction was significantly higher for the encapsulated than for the free flavonoid at 434 
0.25 mg/mL.  435 
436 
Table 1. Antiviral activity of free and encapsulated EGCG against murine norovirus 437 
[Sample] 
(mg/mL)
Theoretical 
[EGCG] 
(mg/mL) 
2 h Overnight 
Recovered 
titer 
(TCID50/mL)
Reduction
Recovered 
titer 
(TCID50/mL) 
Reduction
PBS -  6.45 ± 0.35 A - 5.87 ± 0.38 A - 
Free 
EGCG 
2.5 2.5 4.13 ± 0.10 B 2.32 <1.15 B >4.72 
0.25 0.25 6.03 ± 0.12 A 0.42 4.71 ± 0.12 C 1.16 
EGCG-
loaded 
chitosan
25 2.5 5.20 ± 0.00 C 1.25 <1.15 B >4.72 
2.5 0.25 6.07 ± 0.21 A 0.38 3.48 ± 0.38 D 2.39 
* Within each column, different letters (A, B, C and D) denote significant differences between 438 
treatments (p < 0.05). 439 
440 
Given that the unloaded electrosprayed chitosan did not show antiviral activity (data not 441 
shown), these results can be explained considering that the bioactive compound might 442 
have been gradually released from the microcapsules. In fact, a sustained release of 443 
bioactives is often desirable and pursued through their encapsulation (Singh, 2010). In 444 
our system, the lower antiviral activity of encapsulated EGCG at short exposure times 445 
and its substantial increase at longer time periods suggested a gradual release of the 446 
active compound from the chitosan capsules, mainly ascribed to a Fickian diffusion 447 
mechanism with some contribution from polymer relaxation phenomena. This result is 448 
consistent with the release profiles obtained for similar systems based on EGCG-loaded 449 
chitosan microcapsules (Gómez-Mascaraque, Soler & López-Rubio, 2016). On the 450 
other hand, the fact that the reduction in the recovered titer was higher for the 451 
encapsulated EGCG after an overnight incubation implied that free EGCG was less 452 
active against the MNV than the EGCG released from the capsules. As the assay was 453 
carried out in PBS at 37ºC to mimic physiological conditions, this can be easily 454 
explained by the great instability of EGCG in slightly alkaline solutions (Sang, Lee, 455 
Hou, Ho & Yang, 2005; Su, Leung, Huang & Chen, 2003; Wang, Zhou & Wen, 2006). 456 
Therefore, the results suggested that while free EGCG degraded with time in PBS, 457 
microencapsulation of the compound within the electrosprayed chitosan particles 458 
delayed its degradation, hence protecting its antiviral activity in simulated physiological 459 
conditions.        460 
461 
4. Conclusions 462 
There was a small range of molecular weight Ð concentration combinations which gave 463 
rise to electrosprayed particles without leading to solution dripping or fiber formation. 464 
Both parameters caused a considerable increase in the viscosity of the solutions, 465 
although the values of the viscosity on their own were not enough to predict whether a 466 
particular chitosan solution would lead to fiber-free particles. A Discriminant Function 467 
Analysis revealed that the surface tension and the electrical conductivity of the solutions 468 
were also relevant properties in predicting the obtained morphologies. The analysis 469 
allowed the accurate prediction of 84.2% of the electrosprayed chitosan solutions. The 470 
chitosan with the lowest assayed molecular weight (25 kDa), which allowed the highest 471 
electrosprayable concentration (5% w/v) and thus the highest productivity, was used to 472 
produce EGCG-loaded encapsulation structures achieving an encapsulation efficiency 473 
close to 80%. Microencapsulated EGCG showed prolonged antiviral activity against 474 
murine norovirus as compared to the free compound, suggesting that EGCG was 475 
gradually released from the chitosan capsules and that the encapsulation matrix exerted 476 
a protective effective on the active compound against degradation in simulated 477 
physiological conditions. 478 
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